Clinical trialNCT07661329RecruitingPhase 3Interventional

A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

SponsorYS Life Science Co., Ltd.Enrollment600Ocular Hypertension (OH)Primary Open Angle Glaucoma (POAG)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of AbbVie INC in subjects with primary open angle glaucoma (POAG) or ocular hypertension.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

National Clinical Trials
Beverly Hills, California, United States
James Khodabakhsh, Dr
Not, yet, recruiting
United Medical Research Institute
Inglewood, California, United States
James H Peace, Dr
Not, yet, recruiting
Eye Research Foundation, Inc.
Newport Beach, California, United States
David Wirta, Dr.
Recruiting
Visionary Eye Research Institute
Newport Beach, California, United States
Ehsan Sadri, Dr
Not, yet, recruiting
North Bay Eye Associates
Petaluma, California, United States
Jason Bacharach, Dr
Not, yet, recruiting
Advanced Research, Llc
Boynton Beach, Florida, United States
Sirtaz Sibia, Dr
Not, yet, recruiting
Quantum Clinical Trials
Miami Beach, Florida, United States
Shani Reich, Dr
Not, yet, recruiting
Advanced Research, Llc
Weston, Florida, United States
Aarub Kubal, Dr
Not, yet, recruiting
Clayton Eye Clinical Research
Morrow, Georgia, United States
Lauren Dubiner, Dr
Not, yet, recruiting
Coastal Research Associates, Llc
Roswell, Georgia, United States
Douglas G Day, Dr
Not, yet, recruiting
the Eye Care Institute
Louisville, Kentucky, United States
Brennan P Greene, Dr
Not, yet, recruiting
Ophthalmology Associate (eye Care)
St Louis, Missouri, United States
Rajan P Malhotra, Dr
Not, yet, recruiting
Tekwani Vision Center
St Louis, Missouri, United States
Navin Tekwani, Dr
Not, yet, recruiting
Rochester Ophthalmological Group
Rochester, New York, United States
Paul Hartman, Dr
Not, yet, recruiting
Houston Eye Associates
Houston, Texas, United States
Kevin Y Jong, Dr
Not, yet, recruiting
R and R Eye Research
San Antonio, Texas, United States
Anhtuan Nguyen, Dr
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bimatoprost ophthalmic solution 0.01% YSBPBimatoprost ophthalmic solution 0.01%

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Jun 2026
Primary completion: 1 Nov 2027
Completion: 31 Dec 2027
Last update posted: 22 Jun 2026
Registered enrollment: 600
Registry id: NCT07661329

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.